€79.02
0.82% today
Paris, Aug 07, 09:45 am CET
ISIN
FR0000120578
Symbol
SAN

Sanofi Stock price

€79.67
-2.77 3.36% 1M
-24.05 23.19% 6M
-14.07 15.01% YTD
-13.70 14.67% 1Y
-17.18 17.74% 3Y
-6.22 7.24% 5Y
-20.04 20.10% 10Y
+9.93 14.24% 20Y
Paris, Closing price Wed, Aug 06 2025
-2.36 2.88%
ISIN
FR0000120578
Symbol
SAN
Industry

Key metrics

Basic
Market capitalization
€100.0b
Enterprise Value
€106.9b
Net debt
€6.9b
Cash
€15.4b
Shares outstanding
1.3b
Valuation (TTM | estimate)
P/E
10.7 | 9.9
P/S
2.3 | 2.2
EV/Sales
2.5 | 2.3
EV/FCF
9.4
P/B
1.4
Dividends
DPS
€3.92
Yield 1Y | 5Y
4.9% | 4.0%
Growth 1Y | 5Y
4.3% | 4.6%
Payout 1Y | 3Y
88.7% | 73.1%
Increased
25 Years
Financials (TTM | estimate)
Revenue
€43.1b | €45.5b
EBITDA
€10.9b | €14.4b
EBIT
€9.5b | €12.1b
Net Income
€9.1b | €10.4b
Free Cash Flow
€11.4b
Growth (TTM | estimate)
Revenue
7.9% | 2.9%
EBITDA
10.0% | 36.5%
EBIT
15.9% | 39.0%
Net Income
116.5% | 87.7%
Free Cash Flow
167.4%
Margin (TTM | estimate)
Gross
71.6%
EBITDA
25.4% | 31.6%
EBIT
22.0%
Net
21.2% | 22.9%
Free Cash Flow
26.4%
Financial Health
Equity Ratio
58.4%
Return on Equity
7.2%
ROCE
9.9%
ROIC
8.7%
Debt/Equity
0.3
More
EPS
€7.4
FCF per Share
€9.1
Short interest
-
Employees
83k
Rev per Employee
€530.0k
Show more

Is Sanofi a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Sanofi Stock Analysis

Unlock Scores for Free

Analyst Opinions

29 Analysts have issued a Sanofi forecast:

20x Buy
69%
9x Hold
31%

Analyst Opinions

29 Analysts have issued a Sanofi forecast:

Buy
69%
Hold
31%

Financial data from Sanofi

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
43,129 43,129
8% 8%
100%
- Direct Costs 12,237 12,237
0% 0%
28%
30,892 30,892
11% 11%
72%
- Selling and Administrative Expenses 8,429 8,429
5% 5%
20%
- Research and Development Expense 7,688 7,688
16% 16%
18%
10,932 10,932
10% 10%
25%
- Depreciation and Amortization 1,465 1,465
17% 17%
3%
EBIT (Operating Income) EBIT 9,467 9,467
16% 16%
22%
Net Profit 9,126 9,126
116% 116%
21%

In millions EUR.

Don't miss a Thing! We will send you all news about Sanofi directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sanofi Stock News

AD HOC NEWS
7 days ago
Weiter florierende Verkäufe mit seinem Kassenschlager Dupixent und ein starkes US-Geschäft haben dem Arzneimittelhersteller Sanofi FR0000120578 im zweiten Quartal Rückenwind beschert.
AD HOC NEWS
7 days ago
Weiterhin florierende Verkäufe mit seinem Kassenschlager Dupixent und ein starkes US-Geschäft haben dem Arzneimittelhersteller Sanofi FR0000120578 im zweiten Quartal Rückenwind beschert.
AD HOC NEWS
16 days ago
(Überflüssiges Wort im letzten Satz des ersten Absatzes gestrichen)PARIS - Der französische Arzneimittelhersteller Sanofi FR0000120578 will mit dem Kauf der britischen Biotechfirma Vicebio für bis zu 1,6 Milliarden US-Dollar sein Geschäft mit Impfungen stärken.
More Sanofi News

Company Profile

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

Head office France
CEO Paul Hudson
Employees 82,878
Founded 1994
Website www.sanofi.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today